Papers
3
Total Citations
27
H-Index
2
About
Xiaole Zhu is a rising authority in robotic urologic oncology, with a focused research program dedicated to optimizing surgical outcomes through advanced meta-analytic methodologies. His work critically evaluates the evolution of robotic-assisted surgery, comparing novel platforms and techniques to establish evidence-based best practices. Zhu’s landmark systematic review and meta-analysis comparing single-port versus multi-port robotic partial nephrectomy, which has garnered 20 citations since 2024, provides crucial insights into perioperative and oncological outcomes, directly informing surgical decision-making for renal tumors. He has further advanced the field by conducting a comprehensive evaluation of the DaVinci and Hugo RAS platforms for robotic radical prostatectomy, a study with 5 citations that addresses the practical implications of emerging surgical systems. Most recently, his 2025 meta-analysis on intracorporeal versus extracorporeal urinary diversion in robotic cystectomy, though newly published, signals his ongoing commitment to refining complex procedures. Through these high-impact, synthesis-driven investigations, Zhu is establishing himself as a key contributor to the evidence base that shapes the future of minimally invasive urologic surgery, offering clear guidance for surgeons navigating technological advancements.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3